Olaparib PARP Inhibitor - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Representative image showing large-scale iron ore mining operations, reflecting investor focus on Rio Tinto plc’s capital intensity, iron ore margins, and balance-sheet pressures following its 2025 results and share price decline.

Fortescue (ASX: FMG) shares fall as $525m Iron Bridge impairment overshadows record shipments

CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years

Saudi Arabia unveils 14-country maritime coalition to protect Red Sea shipping

WSP Global’s second Arcadis approach fails on price and paper currency concerns

Read More

Pharma Industry News

Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible

In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name…

byPallavi Madhiraju

March 13, 2024

web analytics